BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
169 hedge funds and large institutions have $2.74B invested in bluebird bio in 2014 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 53 increasing their positions, 42 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+46
Holders Change %
+37.4%
% of All Funds
4.51%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.19%
New
59
Increased
53
Reduced
42
Closed
11
Calls
$43.4M
Puts
$14.5M
Net Calls
+$28.8M
Net Calls Change
+$16.1M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$4.08M |
| 2 |
DM
Deerfield Management
New York
|
$78M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$46.4M |
| 4 |
QF
QVT Financial
New York
|
$14.9M |
| 5 |
State Street
Boston,
Massachusetts
|
$49.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TC
176
TFS Capital
West Chester,
Pennsylvania
| – | -$802K | -1,725 | Closed |
|
177
Jane Street
New York
| – | -$707K | -1,522 | Closed |
|
|
JRP
178
Jasper Ridge Partners
Menlo Park,
California
| – | -$512K | -1,101 | Closed |
|
179
BNP Paribas Financial Markets
Paris,
France
| – | -$45.9K | -99 | Closed |
|
|
PTC
180
Private Trust Company
Cleveland,
Ohio
| – | -$1K | -2 | Closed |
|